Gene expression analysis of the SdeAB multidrug efflux pump in antibiotic-resistant clinical isolates of Serratia marcescens

被引:10
作者
Dalvi, S. D. [1 ]
Worobec, E. A. [1 ]
机构
[1] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Antibiotic resistance; drug efflux pumps; fluoroquinolones; Serratia marcescens; SdeAB; HOMOLOG; CLONING;
D O I
10.4103/0255-0857.99491
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: Many isolates of Serratia marcescens, a well-known opportunistic pathogen, can be multidrug resistant. Fluoroquinolones are among the most important groups of antibiotics used for treatment of these organisms. However, fluoroquinolone resistance among S. marcescens isolates is fast increasing. Drug extrusion through efflux pumps like SdeAB/HasF is one of the major mechanisms of resistance to fluoroquinolones. This study was carried out to analyze, through gene expression analysis of sdeB, the relative contribution of this mechanism toward fluoroquinolone resistance in clinical isolates of Serratia. Materials and Methods: Total RNA from 45 clinical isolates of S. marcescens was isolated. Quantitative real-time RT PCR was performed on the extracted RNA to study the gene expression of sdeB and was normalized to the sdeB expression in the standard strain of S. marcescens. Results: Of the 45 isolates analyzed, sdeB expression was found to be elevated in 20 isolates (44%). Of these 20 isolates, eight (40%) were fully resistant to at least one of the fluoroquinolones studied. Conversely, of the 20 isolates that over-expressed sdeB, 12 (60%) were fully sensitive to all fluoroquinolones tested. Conclusions: Drug efflux pumps are an important means of fluoroquinolone resistance among clinically important species ofSerratia. The expression of these pumps can be up-regulated in the presence of antibiotics and have the potential for changing the phenotype from sensitive to resistant, thus contributing to therapeutic failures.
引用
收藏
页码:302 / 307
页数:6
相关论文
共 20 条
  • [1] Abbott SL, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P698
  • [2] Ausubel F. M., 1988, Current protocols in molecular biology
  • [3] The role of the Serratia marcescens SdeAB multidrug efflux pump and ToIC homologue in fluoroquinolone resistance studied via gene-knockout mutagenesis
    Begic, Sanela
    Worobec, Elizabeth A.
    [J]. MICROBIOLOGY-SGM, 2008, 154 : 454 - 461
  • [4] Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes
    Bornet, C
    Chollet, R
    Malléa, M
    Chevalier, J
    Davin-Regli, A
    Pagès, JM
    Bollet, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (04) : 985 - 990
  • [5] An RND-type multidrug efflux pump SdeXY from Serratia marcescens
    Chen, J
    Kuroda, T
    Huda, MN
    Mizushima, T
    Tsuchiya, T
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) : 176 - 179
  • [6] Clinical and Laboratory Standards Institute, 2006, M7A6 CLIN LAB STAND
  • [7] Donnenberg MS., 2005, Mandell, Douglas, and Bennet's Principles and Practice of Infectious Diseases, V6th, P2567
  • [8] QUINOLONE RESISTANCE IN CLINICAL ISOLATES OF SERRATIA-MARCESCENS
    FUJIMAKI, K
    FUJII, T
    AOYAMA, H
    SATO, K
    INOUE, Y
    INOUE, M
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) : 785 - 787
  • [9] Gruber WC, 2004, TXB PEDIAT INFECT DI, P1469
  • [10] Emerging mechanisms of fluoroquinolone resistance
    Hooper, DC
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 337 - 341